At present，the “third-party pharmaceutical logistics” is gradually entering the pharmaceutical logistics market. It is the requirement of the national macro development strategy during the “14th Five-Year Plan” period to implement the regulatory reform of “Balance the streamline of government administration and empowerment” for pharmaceutical logistics；it is also an area that cannot be ignored in the construction of post-marketing regulatory policy for pharmaceutical products. At this stage，while strengthening the quality management of the “third-party pharmaceutical logistics”，the construction of a unified modern pharmaceutical logistics market should be actively promote in China for high-quality development of pharmaceutical logistics. Therefore，it is necessary to fully understand the basic characteristics of modern pharmaceutical logistics and formulate a unified national regulatory policy on modern pharmaceutical logistics. We need to scientifically study and evaluate the safety risk points of “third-party pharmaceutical logistics”，as well as improve the quality management requirements for entrusted matters of the pharmaceutical logistics and the administrative supervision measures on “third-party pharmaceutical logistics.” At the same time，it is important to explore and complete the evaluation mechanism of the third-party pharmaceutical logistics enterprises by industry enterprises.